High-sensitivity C-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: a substudy from the CHARISMA trial

CHARISMA Investigators, Michael Weber, Deepak L. Bhatt, Danielle M. Brennan, Graeme J. Hankey, Steven R. Steinhubl, S. Claiborne Johnston, Gilles Montalescot, Koon-Hou Mak, Keith A. A. Fox, Donald J. Easton, Eric J. Topol, Christian W. Hamm

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'High-sensitivity C-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: a substudy from the CHARISMA trial'. Together they form a unique fingerprint.

Medicine & Life Sciences